Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours

NCT04914026 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT04914026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04914026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours
Lead sponsor
Haukeland University Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2016
Completion date
December 31, 2026
Enrollment
350 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non-seminoma testicular cancer, relapse testicular cancer, seminoma, stage i testicular cancer, stage ii testicular cancer, stage iii testicular cancer, stage iv testicular cancer, testicular germ cell cancer